Restoril - Additional Resources

Additional Resources

The following links are provided for your convenience in order to obtain additional information on sleep and sleep disorders.

American Academy of Sleep Medicine (AASM)
The AASM is a major national organization that supports quality education and research in the field of sleep medicine.
http://www.aasmnet.org/

American Sleep Apnea Association (ASAA)
The ASAA is a nonprofit organization that educates people about sleep apnea and serves as an advocate for people affected by sleep apnea.
http://www.sleepapnea.org/

National Center on Sleep Disorders Research (NCSDR)
The NCSDR, a branch of the National Heart, Lung, and Blood Institute, supports research, scientist training, dissemination of health information, and other activities on sleep disorders and related concerns.
http://www.nhlbi.nih.gov/about/ncsdr/

National Heart, Lung, and Blood Institute (NHLBI)
The Information Center of this particular branch of the National Institutes of Health (NIH) acquires, analyzes, promotes, maintains, and disseminates programmatic and educational information related to sleep disorders and sleep-disordered breathing.
http://www.nhlbi.nih.gov/

National Sleep Foundation (NSF)
The NSF is a nonprofit organization dedicated to improving the quality of life for the millions of Americans who suffer from sleep disorders.
http://www.sleepfoundation.org/

Important safety information: Restoril™ is indicated for the short-term treatment of insomnia (generally 7 to 10 days). The failure of insomnia to remit after 7 to 10 days of treatment may indicate the presence of a primary psychiatric and/or medical illness that should be evaluated. Restoril™ is contraindicated in women who are pregnant or may become pregnant because of the potential risk to the fetus. The most common side effects of Restoril™ are drowsiness, dizziness, lightheadedness, and difficulty with coordination. Severe allergic reactions have been reported in patients taking sedative-hypnotics, including Restoril™. Complex behaviors such as “sleep driving” have also been reported. Although behaviors such as “sleep driving” may occur with Restoril™ alone at therapeutic doses, the use of alcohol or other CNS depressants with Restoril™ appears to increase the risk of these unusual behaviors, as does the use of Restoril™ doses exceeding the maximum recommended dose. Use extreme care while doing anything that requires complete alertness, such as driving a car, operating machinery, or piloting an aircraft.

Healthcare Provider Letter

For more information about Restoril™ (temazepam) capsules, please read the complete prescribing information.